Related Experiment Videos
Appropriate age for measles vaccination in the United States
Insights
Measles vaccination age recommendations vary globally. While 15 months is suitable for developed nations, 9 months is recommended for developing countries due to higher disease risks in younger children.
Area of Science:
- Pediatrics
- Epidemiology
- Immunology
Background:
- Measles vaccination age is critical, balancing disease risk against vaccine efficacy.
- Historically, US measles vaccination began at 9 months due to high disease incidence and complications in infants.
Purpose of the Study:
- To analyze the evolution of measles vaccination age recommendations.
- To compare the appropriateness of current recommendations for developed versus developing countries.
Main Methods:
- Review of historical vaccination policies and epidemiological data in the United States.
- Analysis of measles disease risk and vaccine efficacy across different age groups and geographical regions.
Main Results:
- US vaccination age increased from 9 to 12 months (1965) and then to 15 months (1976) due to improved understanding of vaccine failure and transmission patterns.
- Higher measles disease burden and complication risks in young children in developing countries necessitate earlier vaccination.
Conclusions:
- The 15-month recommendation for measles vaccination is appropriate for developed countries with similar epidemiology to the US.
- A 9-month vaccination age is more appropriate for developing countries facing significant risks of measles in preschool children.
Abstract:
The appropriate age for measles vaccination is determined by weighing the risk of measles disease and complications at a given age with vaccine efficacy at that age. In the United States, measles vaccine was initially used in children as young as 9 months of age because the disease was common and complications were greatest in persons less than 1 year of age. In 1965, when it became apparent that vaccine failure was unacceptably high in children less than 1 year and when epidemiologic analysis indicated that children greater than or equal to 1 year, particularly schoolchildren, were the primary focus of measles transmission, the vaccination age was raised to 12 months. In 1976, further studies showed efficacy was slightly higher at 15 months of age versus 12 months or 12-14 months of age. Because the risk of acquiring measles in children less than 15 months was low, the age for routine vaccination was increased to 15 months. This age recommendation may be appropriate for developed countries where the epidemiology of measles may be similar to the epidemiology in the United States. However, this age is inappropriate for many countries in the developing world where the risks of measles and complications from measles are high in young preschool children. In those countries, the recommended age for routine vaccination against measles is generally 9 months.